TetraLogic Pharmaceuticals (TLOG) Announces Publication Of Structural Characterization Of Birinapant
4/9/2014 8:24:41 AM
MALVERN, Pa., April 9, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that data published in a forthcoming issue of the Journal of Medicinal Chemistry of the American Chemical Society describes the discovery and unique chemical features of its lead Smac-mimetic birinapant, which is currently being tested in Phase 1 and Phase 2 clinical trials for hematological malignancies and solid tumors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by